"Without a strong IP system and strong protections and clear penalties, we won't be able to get our companies funded."

— Unidentified CEO of a VC-backed California company, speaking at last week's MDMA meeting on the outlook for funding for new med-tech firms, "Venture capital growing wary of prospects for new devices."